Taysha Gene Therapies, Inc. — 10-Q Filings
16 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Taysha Gene Therapies, Inc. (TSHA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Taysha Gene Therapies, Inc. has filed 16 10-Q documents with the SEC since 2020. To view all SEC filings by Taysha Gene Therapies, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-263506 | Nov 4, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-107010 | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-072036 | May 15, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-126416 | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-095082 | Aug 12, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-059555 | May 14, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-063734 | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-042089 | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-021333 | May 11, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001564590-22-036936 | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001564590-22-029155 | Aug 11, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001564590-22-020260 | May 16, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001564590-21-056225 | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-044462 | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-026559 | May 11, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001564590-20-053602 | Nov 12, 2020 | Sep 30, 2020 |